GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Tiny variants in a protein that alerts the immune system to the presence of infection may underlie the rare ability of some individuals to control HIV infection without the need for medications. In a recent paper in Science Express, an international research team reports that they discovered that differences in five amino acids in the HLA-B protein are associated with whether or not HIV-infected individuals can control viral levels with their immune system only.

During this week’s podcast Dr. Robin Hardwicke, from the University of Texas Health Science Center in Houston and one of the members of the research team, elaborates on the implications of the study for HIV treatment. She also discusses why HLA-B is such an important protein in relation to immune system functioning and describes the key role played by a genome-wide association study in the paper published in Science Express.

Add a comment

Add a comment

Click here to Login/Register for free. You will be taken back to your selected item after Login/Registration.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

If you have any questions about your subscription, click
hereto email us or call at (914) 740-2189.

You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
more.